Clinical Trial Update: Lenalidomide After Allo Transplant [Phase 1]

View source ↗

Summary

A Phase 1 trial of lenalidomide after allogeneic transplant in patients with multiple myeloma or lymphoma was terminated. The update provides the trial's status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Multiple Myeloma

Drugs mentioned

• Revlimid (lenalidomide)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Multiple Myeloma, Lymphoma | Phase 1 | Status: TERMINATED